Joseph Hawkins is a Volunteer Writer at BioNews, and is now a Medical Writer after competing a PhD in Translational Health Sciences at the University of Bristol. His research focused on the potential anti-inflammatory effects of altering nuclear actin dynamics in vascular smooth muscle cells. Previously, he studied Biology at Oxford Brookes University, and went on to obtain an MSc in Molecular Neuroscience at the University of Bristol. He has a broad experience in biological sciences, with specific interests in molecular biology, genetics and cell signalling.
Blood vessels grown in the lab in five days helped to restore blood flow and reduce tissue damage in mice...
Repeated head injuries, such as concussions, may increase the risk of Alzheimer's disease and dementia by reactivating the herpes simplex virus in the brain...
A Phase 3 clinical trial of the investigational drug vutrisiran has shown that it can reduce the risk of death and recurring cardiovascular events in people with a specific heart condition...
A new blood test to detect colon cancer has been approved by the United States Food and Drug Administration...
A CRISPR-based treatment for sickle cell disease is one step closer to approval after an advisory committee for the US Food and Drug Administration met to review its safety...
Genetic variants that may help some people maintain a vegetarian diet better than others have been identified...
Whole genome sequencing is twice as effective as targeted gene sequencing in diagnosing a range of genetic conditions in newborns and infants...
Results from an NHS-based clinical trial show the potential of a blood test to detect over 50 types of cancer...
Deer stem cells have been used to grow antler-like structures on the foreheads of mice, opening the possibility that these cells could be used for limb regeneration in the future...
A gene variant with a protective effect comparable to 'rewinding the heart's biological clock by more than ten years' has been described by an international team of researchers....
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.
